Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Cell Cycle/DNA Damage > Nucleoside Antimetabolite/Analog

Nucleoside Antimetabolite/Analog

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC76220 2'-F-AMP
2'-F-AMP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76219 2'-F-ADP
2'-F-ADP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76218 2-Amino-ATP tetrasodium
2-Amino-ATP tetrasodium is an ATP substitute produced by inserting an amino acid at the C2 position of ATP.
More description
DC76217 2′-O-MOE-CMP
2′-O-MOE-CMP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76216 2′-O-MOE-AMP
2′-O-MOE-AMP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76215 2′-OMe-UMP
2′-OMe-UMP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76214 2′-OMe-UDP
2′-OMe-UDP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76213 2′-OMe-GDP
2′-OMe-GDP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76212 2′-OMe-ADP
2′-OMe-ADP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC76211 2′-F-UDP
2′-F-UDP is a nucleotide analog that can be used in the synthesis of oligonucleotides.
More description
DC7762 RX-3117 Featured
RX-3117 is an orally available and potent DNA synthesis inhibitor with potential antineoplastic activity.
More description
DC73210 TH7528 Featured
TH7528 is a SAMHD1 inhibitor with IC50 of 4.5 μM/2.8 μM/2.6 μM against dGTP/Cl-F-ara-ATP/ara-CTP, respectively.
More description
DC73203 DI-87 Featured
DI-87 ((R)-DI-87) is a highly potent, specific, orally bioavailable deoxycytidine kinase (dCK) inhibitor with IC50 of 3.15 nM.
More description
DC73208 PSB-0963
PSB-0963 (PSB0963) is a potent, selective ecto-5'-Nucleotidase (eN, CD73) inhibitor with Ki of 150 nM, >100-fold selectivity over NTPDases.
More description
DC73207 PSB-0952
PSB-0952 (PSB0952) is a potent, selective ecto-5'-Nucleotidase (eN, CD73) inhibitor with Ki of 260 nM, >150-fold selectivity over NTPDases and P2Y receptor subtypes P2Y2, P2Y4, P2Y6, and P2Y12.
More description
DC73206 PSB-071
PSB-071 (PSB071) is a small molecule inhibitor of nucleoside triphosphate diphosphohydrolases (NTPDase).
More description
DC73205 JLT048
JLT048 is a small molecule inhibitor of tyrosyl-DNA-phosphodiesterases 1 and 2 (TDP1 and TDP2) with IC50 of 7.7 and 32 uM, respectively.
More description
DC73204 F-aza-T-dCyd
F-aza-T-dCyd (NSC801845) is a novel cytidine analog and is more efficacious than aza-T-dCyd in cell culture and mouse xenograft studies in HCT-116 human colon carcinoma.
More description
DC10332 Methylthio-DADMe-Immucillin A; MTDIA Featured
MT-DADMe-ImmA is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP) with a Ki of 90 pM.
More description
DCAPI1525 5-Azacytidine Featured
5-Azacytidine is a potent growth inhibitor and a cytotoxic agent. 5-Azacytidine acts as a demethylating agent by inhibiting DNA methyltransferase (Dnmt), forming covalent adducts with cellular DNMT1 depleting enzyme activity. 5-Azacytidine also improves t
More description
DC10318 Acelarin Featured
Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine.
More description
DC44975 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine Featured
5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine is an adenosine derivative and can be used as an intermediate for oligonucleotides synthesis.
More description
DC72845 N4-Benzoyl-3’-O-methylcytidine
N4-Benzoyl-3’-O-methylcytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities.
More description
DC72843 2’-O-Methyl-N1-methyladenosine
2’-O-Methyl-N1-methyladenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
More description
DC72842 3’-Deoxy-methyl-2-thiouridine
3’-Deoxy-methyl-2-thiouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
More description
DC72019 Fludarabine triphosphate trisodium
Fludarabine triphosphate (F-ara-ATP) trisodium, the active metabolite of Fludarabine, is a potent, noncompetitive and specific inhibitor of DNA primase, with an IC50 of 2.3 μM and a Ki of 6.1 μM. Fludarabine triphosphate trisodium inhibits DNA synthesis by blocking DNA primase and primer RNA formation. Fludarabine triphosphate trisodium inhibits ribonucleotide reductase and DNA polymerase and ultimately leads to cellular apoptosis.
More description
DC7522 Triapine Featured
Triapine is a potent ribonucleotide reductase inhibitor with broad spectrum antitumor activity by inhibiting DNA synthesis. Phase 2.
More description
DC8940 Raltitrexed Featured
Raltitrexed(ZD1694), an inhibitor of thymidylate synthase, is an antimetabolite drug used in cancer chemotherapy.
More description
DC9799 CNDAC Featured
CNDAC is the active component of sapacitabine.
More description
DC72173 L-Cytidine
L-Cytidine is an L-configurational form of Cytidine. L-Cytidine is a pyrimidine nucleoside, a component of RNA. Cytidine can control the glial glutamate cycle, affect brain phospholipid metabolism, catecholamine synthesis and mitochondrial function.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X